1-20 of 28
Lise Tarnow
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

Signe A. Winther, Jens C. Øllgaard, Nete Tofte, Lise Tarnow, Zeneng Wang, Tarunveer S. Ahluwalia, Anders Jorsal, Simone Theilade, Hans-Henrik Parving, Tine W. Hansen, Stanley L. Hazen, Oluf Pedersen, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2019;42(8):1512–1520
https://doi.org/10.2337/dc19-0048
Published: 23 May 2019
View articletitled, Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes
Open the PDF for Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial

Ketan Dhatariya, Stephen C. Bain, John B. Buse, Richard Simpson, Lise Tarnow, Margit Staum Kaltoft, Michael Stellfeld, Karen Tornøe, Richard E. Pratley, the LEADER Publication Committee on behalf of the LEADER Trial Investigators
Journal: Diabetes Care
Diabetes Care 2018;41(10):2229–2235
https://doi.org/10.2337/dc18-1094
Published: 02 August 2018
View articletitled, The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
Open the PDF for The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial in another window
Includes: Supplementary data
Journal Articles

Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes

Emilie H. Zobel, Simone Theilade, Bernt Johan von Scholten, Frederik Persson, Lise Tarnow, Maria Lajer, Tine W. Hansen, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2017;40(3):e32–e33
https://doi.org/10.2337/dc16-2428
Published: 06 January 2017
View articletitled, Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes
Open the PDF for Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes in another window
Journal Articles

Erratum. Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes. Diabetes Care 2015;38: 682–688

Jesper Fleischer, Simon Lebech Cichosz, Pernille Hoeyem, Esben Laugesen, Per Loegstrup Poulsen, Jens Sandahl Christiansen, Lise Tarnow, Troels Krarup Hansen
Journal: Diabetes Care
Diabetes Care 2015;38(11):2188
https://doi.org/10.2337/dc15-er11
Published: 12 October 2015
View articletitled, Erratum. Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes. Diabetes Care 2015;38: 682–688
Open the PDF for Erratum. Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes. Diabetes Care 2015;38: 682–688 in another window
Journal Articles

Increased All-Cause Mortality in Patients With Type 1 Diabetes and High-Expression Mannan-Binding Lectin Genotypes: A 12-Year Follow-up Study

Jakob A. Østergaard, Steffen Thiel, Maria Lajer, Rudi Steffensen, Hans-Henrik Parving, Allan Flyvbjerg, Peter Rossing, Lise Tarnow, Troels K. Hansen
Journal: Diabetes Care
Diabetes Care 2015;38(10):1898–1903
https://doi.org/10.2337/dc15-0851
Published: 15 July 2015
View articletitled, Increased All-Cause Mortality in Patients With Type 1 Diabetes and High-Expression Mannan-Binding Lectin Genotypes: A 12-Year Follow-up Study
Open the PDF for Increased All-Cause Mortality in Patients With Type 1 Diabetes and High-Expression Mannan-Binding Lectin Genotypes: A 12-Year Follow-up Study in another window
Journal Articles

Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes

Jesper Fleischer, Simon Lebech Cichosz, Pernille Hoeyem, Esben Laugesen, Per Loegstrup Poulsen, Jens Sandahl Christiansen, Lise Tarnow, Troels Krarup Hansen
Journal: Diabetes Care
Diabetes Care 2015;38(4):682–688
https://doi.org/10.2337/dc14-0654
Published: 08 January 2015
View articletitled, Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes
Open the PDF for Glycemic Variability Is Associated With Reduced Cardiac Autonomic Modulation in Women With Type 2 Diabetes in another window
Journal Articles

Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study

Johanna W. Nin, MD, Anders Jorsal, MD, Isabel Ferreira, PHD, Casper G. Schalkwijk, PHD, Martin H. Prins, MD, Hans-Henrik Parving, MD, Lise Tarnow, MD, Peter Rossing, MD, Coen D. Stehouwer, MD
Journal: Diabetes Care
Diabetes Care 2011;34(2):442–447
https://doi.org/10.2337/dc10-1087
Published: 20 January 2011
View articletitled, Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study
Open the PDF for Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-year follow-up study in another window
Includes: Supplementary data
Journal Articles

Osteoprotegerin and Mortality in Type 2 Diabetic Patients

Henrik Reinhard, MD, Maria Lajer, PHD, Mari-Anne Gall, DMSC, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC, Lars M. Rasmussen, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2010;33(12):2561–2566
https://doi.org/10.2337/dc10-0858
Published: 07 October 2010
View articletitled, Osteoprotegerin and Mortality in Type 2 Diabetic Patients
Open the PDF for Osteoprotegerin and Mortality in Type 2 Diabetic Patients in another window
Journal Articles

Vitamin D Levels and Mortality in Type 2 Diabetes

Christel Joergensen, MD, Mari-Anne Gall, DMSC, Anne Schmedes, PHD, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2010;33(10):2238–2243
https://doi.org/10.2337/dc10-0582
Published: 06 July 2010
View articletitled, Vitamin D Levels and Mortality in Type 2 Diabetes
Open the PDF for Vitamin D Levels and Mortality in Type 2 Diabetes in another window
Journal Articles

Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy

Maria Lajer, PHD, Anders Jorsal, Lise Tarnow, DMSC, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2010;33(7):1567–1572
https://doi.org/10.2337/dc09-2174
Published: 31 March 2010
View articletitled, Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy
Open the PDF for Plasma Growth Differentiation Factor-15 Independently Predicts All-Cause and Cardiovascular Mortality As Well As Deterioration of Kidney Function in Type 1 Diabetic Patients With Nephropathy in another window
Journal Articles

Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition

Stine E. Nielsen, MD, Takeshi Sugaya, MD, PHD, Lise Tarnow, MD, DMSC, Maria Lajer, CANDSCI, Katrine J. Schjoedt, MD, Anne Sofie Astrup, MD, Tsuneharu Baba, MD, PHD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(9):1684–1688
https://doi.org/10.2337/dc09-0429
Published: 05 June 2009
View articletitled, Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition
Open the PDF for Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition in another window
Journal Articles

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria

Camilla Noelle Rathcke, MD, Frederik Persson, MD, Lise Tarnow, MD, DMSC, Peter Rossing, MD, DMSC, Henrik Vestergaard, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2009;32(2):323–328
https://doi.org/10.2337/dc08-1144
Published: 01 February 2009
View articletitled, YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
Open the PDF for YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria in another window
Journal Articles

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

Anne Sofie Astrup, MD, Lise Tarnow, MD, Lotte Pietraszek, Casper G. Schalkwijk, MD, Coen D.A. Stehouwer, MD, Hans-Henrik Parving, MD, Peter Rossing, MD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1170–1176
https://doi.org/10.2337/dc07-1960
Published: 01 June 2008
View articletitled, Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate
Open the PDF for Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate in another window
Journal Articles

Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Anders Jorsal, Noelynn Oliver, PHD, Peggy Roestenberg, PHD, Yasuhiko Ito, MD, Hans-Henrik Parving, MD, DMSC, Peter Rossing, MD, DMSC, Frans A. van Nieuwenhoven, PHD, Roel Goldschmeding, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(6):1177–1182
https://doi.org/10.2337/dc07-2469
Published: 01 June 2008
View articletitled, Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy
Open the PDF for Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy in another window
Journal Articles

Relation of Left Ventricular Function, Mass, and Volume to NT-proBNP in Type 1 Diabetic Patients

Anne Sofie Astrup, MD, Won Yong Kim, MD, Lise Tarnow, MD, René M. Botnar, PHD, Cheryl Simonsen, RT, Lau Brix, MSC, Lotte Pietraszek, Peter Riis Hansen, MD, Warren J. Manning, MD, Hans-Henrik Parving, MD
Journal: Diabetes Care
Diabetes Care 2008;31(5):968–970
https://doi.org/10.2337/dc07-1536
Published: 01 May 2008
View articletitled, Relation of Left Ventricular Function, Mass, and Volume to NT-proBNP in Type 1 Diabetic Patients
Open the PDF for Relation of Left Ventricular Function, Mass, and Volume to NT-proBNP in Type 1 Diabetic Patients in another window
Journal Articles

Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy

Maria Lajer, MSC, Lise Tarnow, DMSC, Anders Jorsal, Tom Teerlink, DMSC, Hans-Henrik Parving, DMSC, Peter Rossing, DMSC
Journal: Diabetes Care
Diabetes Care 2008;31(4):747–752
https://doi.org/10.2337/dc07-1762
Published: 01 April 2008
View articletitled, Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy
Open the PDF for Plasma Concentration of Asymmetric Dimethylarginine (ADMA) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy in another window
Journal Articles

The Xylosyltransferase I Gene Polymorphism c.343G>T (p.A125S) Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes

Sylvia Schön, PHD, Christian Prante, MS, Claudia Bahr, MS, Lise Tarnow, MD, DMSC, Joachim Kuhn, PHD, Knut Kleesiek, MD, Christian Götting, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(10):2295–2299
https://doi.org/10.2337/dc06-0344
Published: 01 October 2006
View articletitled, The Xylosyltransferase I Gene Polymorphism c.343G>T (p.A125S) Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes
Open the PDF for The Xylosyltransferase I Gene Polymorphism c.343G>T (p.A125S) Is a Risk Factor for Diabetic Nephropathy in Type 1 Diabetes in another window
Journal Articles

Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy

Anne Sofie Astrup, MD, Lise Tarnow, DMSC, Peter Rossing, DMSC, Birgitte V. Hansen, Jannik Hilsted, DMSC, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(2):334–339
https://doi.org/10.2337/diacare.29.02.06.dc05-1242
Published: 01 February 2006
View articletitled, Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy
Open the PDF for Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy in another window
Journal Articles

Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy

Tri Q. Nguyen, MD, Lise Tarnow, MD, DMSC, Steen Andersen, MD, DMSC, Peter Hovind, MD, DMSC, Hans-Henrik Parving, MD, DMSC, Roel Goldschmeding, MD, PHD, Frans A. van Nieuwenhoven, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(1):83–88
https://doi.org/10.2337/diacare.29.01.06.dc05-1670
Published: 01 January 2006
View articletitled, Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy
Open the PDF for Urinary Connective Tissue Growth Factor Excretion Correlates With Clinical Markers of Renal Disease in a Large Population of Type 1 Diabetic Patients With Diabetic Nephropathy in another window
Journal Articles

Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes

Lise Tarnow, MD, DMSC, Peter Hovind, MD, Tom Teerlink, PHD, Coen D.A. Stehouwer, MD, PHD, Hans-Henrik Parving, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2004;27(3):765–769
https://doi.org/10.2337/diacare.27.3.765
Published: 01 March 2004
View articletitled, Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes
Open the PDF for Elevated Plasma Asymmetric Dimethylarginine as a Marker of Cardiovascular Morbidity in Early Diabetic Nephropathy in Type 1 Diabetes in another window